Monoclonal Mouse anti‑Human Alpha4GnT / A4GNT Antibody (clone OTI1B10, Carrier‑free, aa121‑340, WB) LS‑C788784
Monoclonal Mouse anti‑Human Alpha4GnT / A4GNT Antibody (clone OTI1B10, Carrier‑free, aa121‑340, WB) LS‑C788784
Antibody:
Alpha4GnT / A4GNT Mouse anti-Human Monoclonal (aa121-340) (Carrier-free) (OTI1B10) Antibody
Format:
Unconjugated, Carrier-free
Overview
Antibody:
Alpha4GnT / A4GNT Mouse anti-Human Monoclonal (aa121-340) (Carrier-free) (OTI1B10) Antibody
Format:
Unconjugated, Carrier-free
Specifications
Description
A4GNT antibody LS-C788784 is an unconjugated mouse monoclonal antibody to human A4GNT (Alpha4GnT) (aa121-340). Validated for WB.
Target
Human Alpha4GnT / A4GNT
Synonyms
A4GNT | Alpha4GnT
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Purified from ascites.
Modifications
Carrier-free.
Also available
Unmodified.
Immunogen
Human recombinant protein fragment corresponding to amino acids 121-340 of human A4GNT (NP_057245) produced in E.coli.
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, Western blot, ELISA
Species:
Human
Applications:
IHC, Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Western blot
Source:
E. coli
Tag:
6His, N-terminus
Source:
Human
Tag:
Myc-DDK (Flag)
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/26/2024